Frequency of treatable and complex pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia, according to HHT1 versus HHT2 genotype.

MLA

Bradbury, N. C., et al. “Frequency of Treatable and Complex Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia, According to HHT1 versus HHT2 Genotype.” Journal of Vascular & Interventional Radiology, vol. 25, no. 3, Mar. 2014, pp. S51–52. EBSCOhost, https://doi.org/10.1016/j.jvir.2013.12.125.

APA

Bradbury, N. C., O’Hara, R., Taggart, M., McDonald, J., & Whitehead, K. (2014). Frequency of treatable and complex pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia, according to HHT1 versus HHT2 genotype. Journal of Vascular & Interventional Radiology, 25(3), S51–S52. https://doi.org/10.1016/j.jvir.2013.12.125

Chicago

Bradbury, N.C., R. O’Hara, M. Taggart, J. McDonald, and K. Whitehead. 2014. “Frequency of Treatable and Complex Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia, According to HHT1 versus HHT2 Genotype.” Journal of Vascular & Interventional Radiology 25 (3): S51–52. doi:10.1016/j.jvir.2013.12.125.